TACTIC project TACTIC is a project of the Accredited Health Research Institute, Institut de Recerca – Vall d’Hebron University Hospital (IR-HUVH), that addresses the strategic health challenges of non-communicable diseases and rare diseases in order to strengthen research based on systems medicine. The objective is to develop new perspectives for personalized and precision medicine in the fields of cancer, cardiovascular and neurological disorders, and rare diseases from childhood to adulthood. Complementary axes TACTIC is structured around two transversal axes, which are complementary to each other. The first axis is precision diagnosis and prognosis prediction, including computational biomedicine and non-invasive diagnosis. And the second, innovative therapies, with new molecular mechanisms and new therapeutic modalities. Research based on systems medicine The actions encompassed in the TACTIC program are based on the philosophy of systems medicine. This includes patient-centered medicine, primary and hospital care, translational research, computational biomedicine, and the transfer to clinical practice and impact on society. Opportunities Organizational chart Participating groups The TACTIC project is made up of five research groups, four from the Vall d’Hebron Institut de Recerca (VHIR) and one from the Vall d’Hebron Institut d’Oncologia (VHIO) Childhood Cancer and Blood Disorders Clinical Biochemistry, Drug Delivery & Therapy Cardiovascular Diseases Clinical Neuroimmunology Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases Upper Gastrointestinal and Endocrine Tumors Group Cancer Computational Biology Group Related news The INTEGRA programme incorporates patients' voices to advance research into rare anaemias The integration of Patient-Reported Outcome Measures (PROMs) will make it possible to incorporate patients' experiences and quality of life into research on sickle cell disease and other rare anaemias. Ovarian reserve does not predict the course of multiple sclerosis Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age. Two VHIR researchers get awards at ISHR 2026 for studies on arrhythmias and heart failure The award-winning studies open new avenues for preventing arrhythmias caused by air pollution and for developing new therapeutic strategies against heart failure. See more "Fortalece" Program TACTIC is part of the 'Fortalece' program, an initiative of the Ministry of Science and Innovation, which incorporates a renewed model focused on simplifying administrative processes and promoting qualitative transformation. In this way, it seeks to foster cohesive development of research lines, knowledge transfer, the promotion of emerging scientific talent, and the integration of non-scientific actors or disciplinary integration, among others. 'Fortalece' is part of the state program to promote scientific-technical research and its transfer.
